| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/20/1999 | WO1999024021A1 Vitamin composition |
| 05/20/1999 | WO1999024020A1 A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition |
| 05/20/1999 | WO1999024019A1 Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same |
| 05/20/1999 | WO1999024018A1 Method for producing liposomes |
| 05/20/1999 | WO1999024017A1 Novel oral dosage form for carvedilol |
| 05/20/1999 | WO1999024016A1 Emulsions for aerosolization and drug delivery |
| 05/20/1999 | WO1999024015A1 Buffered drug formulations for transdermal electrotransport delivery |
| 05/20/1999 | WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 05/20/1999 | WO1999009995A3 A process for the preparation of solid oral dosage forms comprising alendronic acid |
| 05/20/1999 | WO1999008718A3 Bioresorbable compositions for implantable prostheses |
| 05/20/1999 | WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules |
| 05/20/1999 | CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
| 05/20/1999 | CA2309955A1 Method for decreasing self-association of polypeptides |
| 05/20/1999 | CA2309819A1 A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition |
| 05/20/1999 | CA2309597A1 Sustainedly releasing agents for medicines and sustainedly released medicinal compositions containing the same |
| 05/20/1999 | CA2309542A1 Novel oral dosage form for carvedilol |
| 05/20/1999 | CA2309123A1 Stable antiandrogenic gel composition |
| 05/19/1999 | EP0916395A2 An apparatus for producing a pharmaceutical product |
| 05/19/1999 | EP0916343A1 use of alkzl phosphoric acid compounds for the treatment of psoriatic diseases |
| 05/19/1999 | EP0916340A1 Suppositories |
| 05/19/1999 | EP0916339A1 Prolonged activity nicotine patch |
| 05/19/1999 | EP0916336A1 Transdermal delivery system |
| 05/19/1999 | EP0916333A2 Tablet and/or package for medical applications and/or for health care |
| 05/19/1999 | EP0915819A1 Illudin analogs useful as antitumor agents |
| 05/19/1999 | EP0915701A1 Fast-dissolving galanthamine hydrobromide tablet |
| 05/19/1999 | EP0915693A1 An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin |
| 05/19/1999 | EP0915684A1 Material for buffered resorbable internal fixation devices and method for making same |
| 05/19/1999 | EP0915658A1 Film-building agent useful to protect against infections |
| 05/19/1999 | CN1216942A Two-chamber cartridge for propellant-free metered aerosols |
| 05/19/1999 | CN1216925A Novel Dispersible lipid blends and uses therefor |
| 05/19/1999 | CN1216919A Improvement in the taste of active pharmaceutical ingredients |
| 05/19/1999 | CN1216918A Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 05/19/1999 | CN1216705A Medicine for external use contg. camphor and menthanol, and prepn. method therefor |
| 05/19/1999 | CN1216700A Coolant powders |
| 05/19/1999 | CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives |
| 05/18/1999 | US5905081 Topical formulations of azathioprine to treat inflammatory bowel disorders |
| 05/18/1999 | US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides |
| 05/18/1999 | US5905069 Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 05/18/1999 | US5905000 Nanostructured ion conducting solid electrolytes |
| 05/18/1999 | US5904937 Taste masked pharmaceutical compositions |
| 05/18/1999 | US5904936 Particles based on polyamino acid(s) and capable of being used as delivery vehicles for active principle(s) and method for preparing them |
| 05/18/1999 | US5904935 Delivery of drugs with peptides and proteins |
| 05/18/1999 | US5904934 Osmosis of semipermeable cups, expansion and shapes |
| 05/18/1999 | US5904933 Stable reverse and multiple fluorocarbon emulsions |
| 05/18/1999 | US5904932 Topical preparation containing a suspension of solid lipid particles |
| 05/18/1999 | US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide |
| 05/18/1999 | US5904930 Hydroxytamoxifen derivatives in solutions |
| 05/18/1999 | US5904929 Acylated cyclodextrin-containing pharmaceutical composition |
| 05/18/1999 | US5904927 Drug delivery using pH-sensitive semi-interpenetrating network hydrogels |
| 05/18/1999 | US5904923 Methods for preparing pharmaceutical compositions and using same to treat drug addiction |
| 05/18/1999 | US5904916 Enhancers; administering mixed foral odorants; rehabilitation of patients diagnosed with pathologically induced learning disabilities |
| 05/18/1999 | US5904144 Method for delivering a biologically active molecule to the eye |
| 05/18/1999 | CA2140639C Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/14/1999 | WO1999023237A1 Transfecting peptide vector, composition containing same and applications |
| 05/14/1999 | WO1999023012A1 Package of sheet-type patches |
| 05/14/1999 | WO1999023011A1 Kits containing cyanoacrylate compositions comprising an antimicrobial agent |
| 05/14/1999 | WO1999023010A1 Methods and compositions for treating dermatoses |
| 05/14/1999 | WO1999022934A1 Prepolymer compositions comprising an antimicrobial agent |
| 05/14/1999 | WO1999022802A1 Method and apparatus for applying 5-aminolevulinic acid |
| 05/14/1999 | WO1999022772A1 LIPOSOMAL OLIGONUCLEOTIDE COMPOSITIONS FOR MODULATING ras GENE EXPRESSION |
| 05/14/1999 | WO1999022769A1 Gellan gum tablet coating |
| 05/14/1999 | WO1999022768A1 Controlled release compositions comprising gellan gum gels |
| 05/14/1999 | WO1999022767A1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both |
| 05/14/1999 | WO1999022763A2 Encapsulated immunomodulators useful as vaccine adjuvants |
| 05/14/1999 | WO1999022754A1 Method for administering acylated insulin |
| 05/14/1999 | WO1999022752A1 Composition and method for increasing insulin activity |
| 05/14/1999 | WO1999022747A1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 05/14/1999 | WO1999022742A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | WO1999022741A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | WO1999022739A1 Medicinal steroid compound composition |
| 05/14/1999 | WO1999022738A1 Compositions of lipid lowering agents |
| 05/14/1999 | WO1999022727A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine |
| 05/14/1999 | WO1999022724A2 Extended release formulation containing venlafaxin |
| 05/14/1999 | WO1999022719A1 Capsular preparation containing unsaturated fatty acid or derivative thereof and process for producing the same |
| 05/14/1999 | WO1999022718A1 Effervescent granules |
| 05/14/1999 | WO1999022717A1 Novel formulation for use in pain management |
| 05/14/1999 | WO1999022716A1 Topical compositions for nsai drug delivery |
| 05/14/1999 | WO1999022715A1 Sustained release eyedrops |
| 05/14/1999 | WO1999022714A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | WO1999022713A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 05/14/1999 | WO1999022703A1 Improved personal care formulations |
| 05/14/1999 | WO1999022680A1 Pessary with medicated cartridge |
| 05/14/1999 | WO1999013862A3 A pharmaceutical composition for treating dysmenorrhea and premature labor |
| 05/14/1999 | WO1999008649A3 Foaming skin cream |
| 05/14/1999 | WO1999003508A9 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/14/1999 | WO1999002183A3 A method of inducing a ctl response |
| 05/14/1999 | WO1999002134A3 Method for producing active agent preparations with controlled release from a matrix |
| 05/14/1999 | WO1998053799A9 Immunogenic compositions |
| 05/14/1999 | WO1998052603A3 An influenza enveloped dna vaccine |
| 05/14/1999 | CA2309165A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | CA2309122A1 Novel formulation for use in pain management |
| 05/14/1999 | CA2308852A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | CA2308385A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | CA2308291A1 Controlled release compositions comprising gellan gum gels |
| 05/14/1999 | CA2308136A1 Method for administering acylated insulin |
| 05/14/1999 | CA2307887A1 Gellan gum tablet coating |
| 05/14/1999 | CA2307886A1 Improved personal care formulations |
| 05/14/1999 | CA2307743A1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 05/14/1999 | CA2307558A1 Effervescent granules |
| 05/14/1999 | CA2307541A1 Encapsulated immunomodulators useful as vaccine adjuvants |